No Detail Found!

Comparison of Levobunolol 0.5% with Brimonidine 0.2% to Prevent Mean Intraocular Pressure Elevation after Neodymium: Yatrium- Aluminium Garnet Laser Capsulotomy.

Author(s)
Muhamad Manzoor Combined Military Hospital Lahore/National University of Medical Sciences (NUMS) Pakistan
Dilshad Ali Armed Forces Institute of Cardiology(AFIC), National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Bilal Murtaza 61 Medical Battalion, Multan, Pakistan
Abid Naqvi Combined Military Hospital Gujranwala/National University of Medical Sciences (NUMS), PakistanCombined Military Hospital Lahore/National University of Medical Sciences (NUMS), Pakistan
Asfandyar Combined Military Hospital Gujranwala/National University of Medical Sciences (NUMS)Pakistan
Abstract
Objective: The objective was to compare 0.5% levobunolol with 0.2% brimonidine in terms of mean reduction of intraocular pressure to prevent post neodymium: Yatrium-aluminium garnet (Nd:YAG) laser capsulotomy pressure spike. Study Design: Randomized controlled trial. Place and Duration of Study: The study was conducted at Ophthalmology Department of Combined Military Hospital Peshawar from Mar 2014 to Sep 2014. Material and Methods: A total of 190 patients (95 in each group) were included in this study. In group-1 and group-2 patients, one drop brimonidine 0.2% and levobunolol 0.5% was instilled one hour before the Nd:YAG laser capsulotomy, respectively. Posterior capsulotomy was carried out with Nd:YAG laser. One drop of the respective drug instilled just after the laser treatment to each group. Intraocular pressure was measured with goldman applanation tonometer (GAT) 2 hours after Nd:YAG laser capsulotomy. Results: Mean age was 62.64 ± 4.48 years for group-1 and 62.76 ± 4.50 years for group-2. Gender distribution was as follows: 56 patients (59.0%) were male and 39 patients (41.0%) were female in group-1 while 59 patients (62.1%) were male and 36 patients (37.9 %) were female in group-2. In group-1 baseline mean IOP was 13.72 ± 2.24 and in group-2 it was 13.94 ± 1.98 (p=0.474). At 2 hours post YAG, IOP was 14.92 ± 2.21 and 15.85 ± 1.98 in group-1 and group-2, respectively (p=0.003). Conclusion: Present study provide substantial evidence in favour of brimonidine for prevention of rise in IOP after Nd:YAG laser posterior capsulotomy.
Publication Details
Page(s) 96-100
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 1, Year: 2018

Request the full text from PASTIC

References
PallikarisIG,StojanovicNR,GinisHS, 2016.A new endocapsular open ring for prevention of anterior and posterior capsule opacification,Clinical ophthalmology 10 2205 -12
Garcia-MedinaJJ,Del Rio-VellosilloM,Zanon-MorenoV,Santos-BuesoE,Gallego-PinazoR,FerrerasA, 2015.Does posterior capsule opacification affect the results of diagnostic technologies to evaluate the retina and the optic disc? BioMed research international, 813242 -
HazraS,PaluiH,VemugantiGK, 2012.Comparison of design of intraocular lens versus the material for PCO prevention,Int J Ophthalmol 5 59 -63
MajdabadiA,AbazariM., 2015.Study of Interaction of Laser with tissue using monte carlo method for 1064nm NeodymiumDoped Yttrium Aluminium Garnet (Nd:YAG) Laser,Lasers Med Sci 6 22 -7
NisarS,MahmoodT,RehmanD, 2008.Comparison of intraocular pressure lowering effect of 0.5% levobunolol and 0.5% timolol maleate after Nd: YAG laser capsulotomy,Pak J Ophthalmol 24 4 -
AriS,CingϋAK,SahinA,CinarY,CaçaI., 2012.The effects of Nd:YAG laser posterior capsulotomy on macular thickness, intraocular pressure, and visual acuity,Ophthalmic Surg Lasers Imaging 43 395 -400
SinghalD,DesaiR,DesaiS,ShastriM,SaxenaD, 2011.Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy,J Pharmacol Pharmacother 2 104 -6
MinelloAA,Prata JuniorJA,MelloPA, 2008.Efficacy of topic ocular hypotensive agents after posterior capsulotomy,Arq Bras Oftalmol 71 706 -10
PolakM,ZarnoqakT, 2002.Results of Nd: YAG laser capsulotomy in posterior capsule opacification,Ann Univ Mariae Curie Sklodowska 51 357 -63
LovicuFJ,ShinEH,McAvoyJW, 2016.Sprouty regulation of TGFbeta-signaling prevents lens EMT leading to cataract,Exp Eye Res 142 92 -101
FathallahM,EltanamlyRM,SaadeldinH,ElnahryGH, 2016.Causes of suboptimal corrected visual acuity following phacoemulsification in a teaching university hospital,Eur J Ophthalmol 27 169 -73
OztasZ,PalamarM,AfrashiF,YagciA, 2015.The effects of Nd:YAG laser capsulotomy on anterior segment parameters in patients with posterior capsular opacification,Clin Exp Optom 98 168 -71
MinJK,AnJH,YimJH, 2014.A new technique for Nd:YAG laser posterior capsulotomy,Int J Ophthalmol 7 345 -9
KaraN,EvcimenY,KirikF,AgachanA,YigitFU, 2014.Comparison of two laser capsulotomy techniques: cruciate versus circular,Semin Ophthalmol 29 151 -5
DanieleAR, 1989.Performing the posterior capsulotomy,Highl Ophthalmol 17 7 -11
RakafskyS,KochDD,FaulknerJD, 1997.Levobunolol 0.5% and timolol maleate 0.5% to prevent intraocular pressure elevations after Nd-YAG laser posterior capsulotomy,J Cataract Refract Surg 23 1075 -80
SeongGJ,LeeYG,LeeJH, 2000.Effect of 0.2% bromonidine in preventing intraocular pressure elevation after Nd-YAG laser posterior capsulotomy,Ophthalmic Surg Laser 31 308 -14
YeomHY,LeeJH,HongYJ, 2006.Prophylactic effect on IOP elevation after Nd:YAG laser posterior capsulotomy,J Ocul Pharmacol Ther 22 176 -81
0

Citations

0

Downloads

97

Views